JNJ-73763989

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for JNJ-73763989, covering 2024-03-06 to 2025-05-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection [Phase 1]

See pricing